{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:19:30Z","timestamp":1792196370550,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS126866"],"award-info":[{"award-number":["1R21NS126866"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014842","name":"Race to Erase MS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ebiom.2025.105721","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T14:57:54Z","timestamp":1746716274000},"page":"105721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Faecal mucoprotein MUC2 is decreased in multiple sclerosis and is associated with mucin degrading bacteria"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8030-3164","authenticated-orcid":false,"given":"Luke A.","family":"Schwerdtfeger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-0741","authenticated-orcid":false,"given":"Federico","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-9894","authenticated-orcid":false,"given":"Laura M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2025.105721_bib1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ana.26084","article-title":"Gut microbiome in progressive multiple sclerosis","volume":"89","author":"Cox","year":"2021","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105721_bib2","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/acn3.51441","article-title":"Gut microbiome is associated with multiple sclerosis activity in children","volume":"8","author":"Horton","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ebiom.2025.105721_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105721_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105721_bib5","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-017-0582-3","article-title":"Intestinal permeability in relapsing-remitting multiple sclerosis","volume":"15","author":"Buscarinu","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105721_bib7","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/BF02100148","article-title":"Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability","volume":"41","author":"Yacyshyn","year":"1996","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105721_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18094621","article-title":"Detection of dysbiosis and increased intestinal permeability in brazilian patients with relapsing-remitting multiple sclerosis","volume":"18","author":"Pellizoni","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5507\/bp.2023.033","article-title":"Impaired intestinal permeability in patients with multiple sclerosis","volume":"169","author":"Fialova","year":"2025","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.ebiom.2025.105721_bib11","article-title":"Increased intestinal permeability in primary Sjogren's syndrome and multiple sclerosis","volume":"4","author":"Sjostrom","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105721_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","article-title":"The role of goblet cells and mucus in intestinal homeostasis","volume":"19","author":"Gustafsson","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105721_bib13","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14363","article-title":"Vasoactive intestinal peptide regulates ileal goblet cell production in mice","volume":"8","author":"Schwerdtfeger","year":"2020","journal-title":"Physiol Rep"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105721_bib14","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1016\/j.cell.2022.09.024","article-title":"Nociceptor neurons direct goblet cells via a CGRP-RAMP1 axis to drive mucus production and gut barrier protection","volume":"185","author":"Yang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105721_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1111911","article-title":"Excessive consumption of mucin by over-colonized Akkermansia muciniphila promotes intestinal barrier damage during malignant intestinal environment","volume":"14","author":"Qu","year":"2023","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105721_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41564-024-01911-7","article-title":"Carbohydrate-active enzymes from Akkermansia muciniphila break down mucin O-glycans to completion","volume":"10","author":"Bakshani","year":"2025","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12182","article-title":"The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system","volume":"260","author":"Pelaseyed","year":"2014","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib18","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1038\/s41598-022-11819-z","article-title":"Characterizing the mucin-degrading capacity of the human gut microbiota","volume":"12","author":"Glover","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105721_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib20","doi-asserted-by":"crossref","first-page":"e00009","DOI":"10.1128\/mSystems.00009-15","article-title":"Improved bacterial 16S rRNA gene (V4 and V4-5) and fungal internal transcribed spacer marker gene primers for microbial community surveys","volume":"1","author":"Walters","year":"2016","journal-title":"mSystems"},{"issue":"D1","key":"10.1016\/j.ebiom.2025.105721_bib21","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gkab1045","article-title":"The carbohydrate-active enzyme database: functions and literature","volume":"50","author":"Drula","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105721_bib22","article-title":"Gut microbiota and metabolites are linked to disease progression in multiple sclerosis","volume":"6","author":"Schwerdtfeger","year":"2025","journal-title":"Cell Rep Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105721_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41587-020-0550-z","article-title":"Overcoming barriers to early disease intervention","volume":"38","author":"Caicedo","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13059-022-02655-5","article-title":"LinDA: linear models for differential abundance analysis of microbiome compositional data","volume":"23","author":"Zhou","year":"2022","journal-title":"Genome Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105721_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad470","article-title":"ggpicrust2: An R package for PICRUSt2 predicted functional profile analysis and visualization","volume":"39","author":"Yang","year":"2023","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105721_bib27","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2025.105721_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103751","article-title":"MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis","volume":"74","author":"Yao","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S2468-1253(22)00241-2","article-title":"The intestinal barrier in disorders of the central nervous system","volume":"8","author":"Pellegrini","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2025.105721_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689723","article-title":"Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson's disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front Neurosci"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105721_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","article-title":"Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson's disease - the RESISTA-PD trial","volume":"20","author":"Becker","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.ebiom.2025.105721_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106948","article-title":"Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson's disease","volume":"123","author":"Rajkovaca Latic","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ebiom.2025.105721_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105721_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease","volume":"54","author":"Costa","year":"2005","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105721_bib35","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: from biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105721_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jcag\/gwaa009","article-title":"Fecal calprotectin, CRP and leucocytes in IBD patients: comparison of biomarkers with biopsy results","volume":"4","author":"Kyle","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"issue":"36","key":"10.1016\/j.ebiom.2025.105721_bib37","doi-asserted-by":"crossref","first-page":"22402","DOI":"10.1073\/pnas.2011703117","article-title":"Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis","volume":"117","author":"Takewaki","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105721_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114785","article-title":"Tyzzerella nexilis strains enriched in mobile genetic elements are involved in progressive multiple sclerosis","volume":"43","author":"Takewaki","year":"2024","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105721_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12866-019-1685-2","article-title":"Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity","volume":"19","author":"Kozhieva","year":"2019","journal-title":"BMC Microbiol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105721_bib40","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acn3.51004","article-title":"Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes","volume":"7","author":"Reynders","year":"2020","journal-title":"Ann Clin Transl Neurol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:17:09Z","timestamp":1762618629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S2352396425001653"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105721","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faecal mucoprotein MUC2 is decreased in multiple sclerosis and is associated with mucin degrading bacteria","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105721"}}